BGB116673

Synonyma:: Catadegbrutinib;(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-[4-[[1-[4-[2,4-dioxotetrahydropyrimidin-1(2H)-yl]phenyl]-4-piperidyl]methyl]-1-piperazinyl]-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide;(R)-3-(tert-Butyl)-N-(1-(4-(6-(6-(4-((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)pyridin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)ethyl)-1,2,4-oxadiazole-5-carboxamide;1,2,4-Oxadiazole-5-carboxamide, 3-(1,1-dimethylethyl)-N-[(1R)-1-[2-methyl-4-[6-[6-[4-[[1-[4-(tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]-4-piperidinyl]methyl]-1-piperazinyl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]phenyl]ethyl]-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 11

BGB116673 Eigenschaften

SMILES: CC1=C(C=CC(=C1)C1N=CN=C2NC(C3=CN=C(N4CCN(CC4)CC4CCN(C5C=CC(N6CCC(NC6=O)=O)=CC=5)CC4)C=C3)=CC=12)[C@@H](C)NC(C1ON=C(N=1)C(C)(C)C)=O

Global( 11)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Accela ChemBio Inc.	+1-858-6993322	info@accelachem.com	United States	21193	58
Chengdu PEIP Pharmaceutical Technology Co., LTD.	028-61715638 18011352545	1242335275@qq.com	China	399	58
Shanghai XingMo Biotechnology Co., Ltd.	+86 13524779951; 13524779951	2075692521@qq.com	China	310	55
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4645	55
Shanghai SuperLan Chemcial Technique Centre	021-2022843681 15618226720	lucy@atkchemical.com	China	10016	58
Chuzhou KeMail Chemical Technology Co., Ltd	0550-5196001 15000891977	wj520wjxby@126.com	China	1941	55
Bide Pharmatech Ltd.	400-1647117 13681763483	product02@bidepharm.com	China	62320	58
Shaoyuan Technology (Shanghai) Co., Ltd.	021-50795510 4000665055	sy-c6@accelachem.com	China	10000	58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd	025-58851090 17714375163	2881759498@qq.com	China	13011	58
Taizhou Chuanxu Pharmaceutical Technology Co., Ltd.	13000000000	974144639@qq.com	China	9284	58

(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-[4-[[1-[4-[2,4-dioxotetrahydropyrimidin-1(2H)-yl]phenyl]-4-piperidyl]methyl]-1-piperazinyl]-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide
1,2,4-Oxadiazole-5-carboxamide, 3-(1,1-dimethylethyl)-N-[(1R)-1-[2-methyl-4-[6-[6-[4-[[1-[4-(tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]-4-piperidinyl]methyl]-1-piperazinyl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]phenyl]ethyl]-
Catadegbrutinib
(R)-3-(tert-Butyl)-N-(1-(4-(6-(6-(4-((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)pyridin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)ethyl)-1,2,4-oxadiazole-5-carboxamide
2736508-60-2